Iteos Therapeutics Inc (ITOS) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access ITOS Annual Balance Sheets →
Observing balance sheet movements over recent quarters helps explain how Iteos Therapeutics Inc adapts its asset base and funding mix.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2025)
(Mar 31 2025) (Dec 31 2024) (Sep 30 2024) (Jun 30 2024)
Assets
Cash & cash equivalent207.82
Short-term Investments, Total307.61
Cash & Short-term Investments514.00
Grants Receivable, Current0.48
Other Current Assets2.07
Prepaid Expense And Other Assets Current11.02
Total Current Assets528.99
Equipment/Property/Plant Net5.18
Long-term investments74.61
Income Taxes Receivable PR1.79
Other Assets, Noncurrent8.00
Research And Development Tax Credit Receivable Current0.28
Research And Development Tax Credit Receivable Non Current7.96
Restricted Cash Noncurrent0.32
Total Assets623.08
Liabilities
Accounts Payable, Current AC6.25
Employee-related Liabilities, Current AC23.77
Unrecognized Tax Benefits48.79
Total Current Liabilities78.81
Total Long-term Debt0.00
Other liabilities, Noncurrent50.47
Accrued Clinical Trial Costs Current36.46
Deferred Income Current1.48
Grants Repayable6.61
Total Liabilities129.28
Stockholders' Equity
Common Stock Value0.04
Additional Paid In Capital Common Stock633.07
Retained Earnings / Accumulated Deficit-123.12
Other Equity-16.19
Common Stockholder's Equity493.80
Total Stockholder's Equity493.80
Liabilities & Stockholder's Equity623.08
4 historic quarters locked

Sign in to unlock the full Iteos Therapeutics Inc balance sheet history.

About Iteos Therapeutics Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0000950170-25-103529

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.